Showing results (121-130 of 457) with videos related to

Sort By:
Pageof 46
Current Medical Research and Opinion|August 22, 2019
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world dataVibeke Strand, Ruchitbhai Shah, Chris Atzinger, et al.
Expert Opinion on Biological Therapy|April 20, 2022
Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritisVibeke Strand, Lixia Zhang, Alix Arnaud, et al.
Current Medical Research and Opinion|January 31, 2017
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilarVibeke Strand, Giampiero Girolomoni, Martin Schiestl, et al.
The Journal of Rheumatology|June 5, 2003
Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysisManathip Osiri, Beverley Shea, Vivian Robinson, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2019
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
The Lancet. Rheumatology|January 22, 2024
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisLihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trialsJasvinder A Singh, Shuo Yang, Vibeke Strand, et al.
Rheumatology (Oxford, England)|April 28, 2009
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritisJeffrey D Greenberg, Leslie R Harrold, Mary J Bentley, et al.
Pageof 46